Syndax Pharma appoints Pierre Legault to board
Mr. Legault currently serves on the board of Poxel Pharmaceuticals, Iroko Pharmaceuticals and NephroGenex, and he most recently served as board member, chairman, and audit chair, respectively.
Mr. Legault serves on the compensation and other committees, of several leading companies that were successfully acquired, notably, NPS Pharmaceuticals, Forest Laboratories, Eckerd Pharmacy and Tobira Therapeutics.
Mr. Legault’s prior executive experience includes serving as Chief Executive Officer, President, Chief Administrative Officer and Chief Financial Officer of several public companies such as Eckerd Pharmacy, OSI Pharmaceuticals, Prosidion, Ltd, and Rite Aid.
He has also held several senior positions with Sanofi-Aventis and predecessor companies, including President of Worldwide Dermatology Operations.
Mr. Legault studied at McGill University, University of Montreal (HEC), and Harvard Business School, and holds a Six Sigma Green Belt, a BAA, MBA, CA and CPA diploma. ■
LATEST MOVES FROM Massachusetts
- DentaQuest appoints Alison Corcoran as CMO
- RXI Pharma names Gerrit Dispersyn chief development officer
- resTORbio appoints Joan Mannick as CMO
- C&W Services appoints Mike Losier as director
- Charles River Associates appoints Robert A. Whitman to board
More inside POST
Carl Zeiss Meditec H1 revenues rise Earnings